메뉴 건너뛰기
European Urology
Volumn 57, Issue 5, 2010, Pages 774-776
New Insights in Intravesical Treatment for Intermediate- and High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma
Author keywords

[No Author keywords available]
Indexed keywords

BCG VACCINE; EPIRUBICIN; MITOMYCIN C;
EID: 77949489389     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.01.004     Document Type: Editorial
Times cited : (4)
References (8)
  • 1
    • 45849140589 scopus 로고    scopus 로고
    • EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder
    • Babjuk M., Oosterlinck W., Sylvester R., et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 54 (2008) 303-314
    • (2008) Eur Urol , vol.54 , pp. 303-314
    • Babjuk, M.1    Oosterlinck, W.2    Sylvester, R.3
  • 2
    • 32944465832 scopus 로고    scopus 로고
    • Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials
    • Sylvester R.J., van der Meijden A.P.M., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006) 466-477
    • (2006) Eur Urol , vol.49 , pp. 466-477
    • Sylvester, R.J.1    van der Meijden, A.P.M.2    Oosterlinck, W.3
  • 3
    • 77949485656 scopus 로고    scopus 로고
    • Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
    • Sylvester R.J., Brausi M.A., Kirkels W.J., et al. Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 57 (2010) 766-773
    • (2010) Eur Urol , vol.57 , pp. 766-773
    • Sylvester, R.J.1    Brausi, M.A.2    Kirkels, W.J.3
  • 4
    • 41149134455 scopus 로고    scopus 로고
    • Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer
    • Hendricksen K., Witjes W.P.J., Idema J.G., et al. Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer. Eur Urol 53 (2008) 984-991
    • (2008) Eur Urol , vol.53 , pp. 984-991
    • Hendricksen, K.1    Witjes, W.P.J.2    Idema, J.G.3
  • 5
    • 67649431728 scopus 로고    scopus 로고
    • An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer
    • Malmström P.-U., Sylvester R., Crawford D.E., et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 56 (2009) 247-256
    • (2009) Eur Urol , vol.56 , pp. 247-256
    • Malmström, P.-U.1    Sylvester, R.2    Crawford, D.E.3
  • 6
    • 0038579265 scopus 로고    scopus 로고
    • Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density
    • Stein J.P., Cai J., Groshen S., and Skinner D.G. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170 (2003) 35-41
    • (2003) J Urol , vol.170 , pp. 35-41
    • Stein, J.P.1    Cai, J.2    Groshen, S.3    Skinner, D.G.4
  • 7
    • 40749132537 scopus 로고    scopus 로고
    • High throughput molecular diagnostics in bladder cancer-on the brink of clinical utility
    • Zieger K. High throughput molecular diagnostics in bladder cancer-on the brink of clinical utility. Mol Oncol 1 (2008) 384-394
    • (2008) Mol Oncol , vol.1 , pp. 384-394
    • Zieger, K.1
  • 8
    • 52949114606 scopus 로고    scopus 로고
    • Bladder cancer subtypes defined by genomic alterations
    • Knowles M.A. Bladder cancer subtypes defined by genomic alterations. Scand J Urol Nephrol 42 Suppl (2008) 116-130
    • (2008) Scand J Urol Nephrol , vol.42 , Issue.SUPPL , pp. 116-130
    • Knowles, M.A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.